Day: January 26, 2026
Chemical
Pharmaceutical
Sci&Tech
Aptamer Drug Development Status and Pipeline
The development of therapeutic aptamers has evolved from a niche technology challenged by pharmacokinetic (PK) issues (stability and renal clearance) to a robust platform. While only two RNA aptamers are currently FDA-approved, the pipeline contains dozens...